ESC 365 - State-of-the-art lecture on cardiovascular residual risk management: role of triglycerides and remnant cholesterol

ESC Professional Premium Access

State-of-the-art lecture on cardiovascular residual risk management: role of triglycerides and remnant cholesterol

Session: Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor J. Jukema (Leiden, NL)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor J Wouter Jukema

Leiden University Medical Center, Leiden (Netherlands (The))

20 presentations

0 follower

3 more presentations in this session

Independent causal effect of remnant cholesterol on atherosclerotic cardiovascular outcomes: a Mendelian randomization study

Speaker: Ms K. Grzelakowska (Bydgoszcz, PL)

Eicosapentaenoic acid, arachidonic acid, and triglyceride levels mediate most of the benefit of icosapent ethyl in REDUCE-IT

Speaker: Professor D. Bhatt (New York, US)

Low HDL cholesterol and hyperglicemia are metabolic syndrome components associated with plaque progression in patients with chronic coronary syndrome: a PARADIGM study

Speaker: Doctor D. Neglia (Pisa, IT)

Access the full session

Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease

Speakers: Professor J. Jukema, Ms K. Grzelakowska, Professor D. Bhatt, Doctor D. Neglia

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources